3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Hyperthermia
1
Breast Neoplasms
1
Interventions
Letrozole
26
Fulvestrant
25
Specimen Handling
20
ribociclib
17
Paclitaxel
16
Capecitabine
16
pembrolizumab
15
palbociclib
15
Trastuzumab
14
Carboplatin
14
exemestane
13
abemaciclib
12
Tamoxifen
12
Anastrozole
12
Magnetic Resonance Spectroscopy
11
pertuzumab
9
trastuzumab deruxtecan
8
Biopsy
8
Goserelin
7
inavolisib
6
giredestrant
6
elacestrant
6
Radiotherapy
6
Cyclophosphamide
6
130-nm albumin-bound paclitaxel
6
patritumab deruxtecan
5
eribulin
5
Taxes
5
Standard of Care
5
Gonadotropin-Releasing Hormone
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
AC protocol
×
30 days
×
Clear all
NCT05889390
2026-05-15
NeoHTerMa
Semmelweis University
Phase 2/3
Active not recruiting
71 enrolled